- Government Procurement
Subject Matter Details
Government Contract Pursued
- Procurement opportunities with respect to its COVID-19 reverse transcriptase-polymerase chain reaction (RT-PCR) test.
Grant, Contribution or Other Financial Benefit
- Funding opportunities for manufacturing in Canada with respect to its COVID-19 reverse transcriptase-polymerase chain reaction (RT-PCR) test.
The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.
Federal Economic Development Agency for Southern Ontario (FedDev)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Public Health Agency of Canada (PHAC)
No government funding was received during the last completed financial year.
Client Contact Information
Suite 1500 – 1055 W Georgia Street
Vancouver, BC V6E 4N7
Hugh Rogers, CEO
Parent Company Information
XPhyto Therapeutics / XPhyto Therapeutics is not a subsidiary of any other parent companies.
Coalition Members Information
XPhyto Therapeutics / XPhyto Therapeutics is not a coalition.
Individual, organization or corporation with a Direct Interest Beneficiary Information
The activities of XPhyto Therapeutics / XPhyto Therapeutics are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Subsidiary Beneficiary Information
XPhyto Therapeutics / XPhyto Therapeutics does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
No public offices held
1 Rideau St Suite 700, Ottawa, ON K1N 8S7
Ottawa, ON K2B 7Y7
Consultant Firm and Address
Wellington-Dupont Public Affairs
2100 Thurston Drive
Ottawa, ON K1G 4K8